Kendra Young
Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 26 | 2024 | 953 | 2.620 |
Why?
| Lupus Erythematosus, Systemic | 10 | 2022 | 250 | 2.540 |
Why?
| Genetic Predisposition to Disease | 17 | 2025 | 2267 | 1.330 |
Why?
| Smoking | 14 | 2024 | 1466 | 1.150 |
Why?
| Tobacco Use Disorder | 4 | 2022 | 239 | 1.060 |
Why?
| Genome-Wide Association Study | 18 | 2025 | 1337 | 0.960 |
Why?
| Receptors, Complement 3d | 10 | 2010 | 140 | 0.940 |
Why?
| Mexican Americans | 2 | 2019 | 113 | 0.940 |
Why?
| Smokers | 9 | 2023 | 138 | 0.900 |
Why?
| Autoantibodies | 8 | 2022 | 1465 | 0.900 |
Why?
| Bronchiectasis | 5 | 2023 | 110 | 0.880 |
Why?
| Vitamin D | 5 | 2022 | 381 | 0.880 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 259 | 0.810 |
Why?
| Coronary Artery Disease | 5 | 2025 | 678 | 0.800 |
Why?
| Polymorphism, Single Nucleotide | 14 | 2025 | 2065 | 0.790 |
Why?
| Herpesvirus 4, Human | 4 | 2019 | 151 | 0.760 |
Why?
| Vitamin D Deficiency | 2 | 2016 | 177 | 0.750 |
Why?
| Diabetes Mellitus, Type 2 | 6 | 2023 | 2437 | 0.730 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 83 | 0.660 |
Why?
| Alanine Transaminase | 2 | 2020 | 150 | 0.650 |
Why?
| Family | 2 | 2014 | 648 | 0.630 |
Why?
| Aspartate Aminotransferases | 1 | 2019 | 85 | 0.630 |
Why?
| Spirometry | 10 | 2024 | 251 | 0.630 |
Why?
| Lipase | 1 | 2019 | 64 | 0.620 |
Why?
| Tomography, X-Ray Computed | 12 | 2024 | 2541 | 0.610 |
Why?
| Inflammation Mediators | 2 | 2019 | 500 | 0.610 |
Why?
| Arthritis, Rheumatoid | 5 | 2024 | 1109 | 0.600 |
Why?
| Virus Attachment | 2 | 2008 | 16 | 0.600 |
Why?
| Cholesterol, HDL | 1 | 2018 | 203 | 0.580 |
Why?
| Smoking Cessation | 1 | 2022 | 408 | 0.580 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 15 | 0.530 |
Why?
| Membrane Proteins | 2 | 2020 | 1109 | 0.520 |
Why?
| Forced Expiratory Volume | 12 | 2024 | 511 | 0.520 |
Why?
| Triglycerides | 1 | 2018 | 524 | 0.510 |
Why?
| Pulmonary Emphysema | 4 | 2024 | 244 | 0.500 |
Why?
| Middle Aged | 33 | 2025 | 31074 | 0.500 |
Why?
| Adiposity | 2 | 2012 | 505 | 0.490 |
Why?
| Metabolic Syndrome | 1 | 2018 | 340 | 0.480 |
Why?
| Humans | 75 | 2025 | 129116 | 0.470 |
Why?
| Genetic Variation | 6 | 2025 | 934 | 0.460 |
Why?
| Insulin-Secreting Cells | 1 | 2018 | 366 | 0.440 |
Why?
| Atherosclerosis | 3 | 2023 | 410 | 0.430 |
Why?
| Insulin Resistance | 2 | 2018 | 1167 | 0.420 |
Why?
| Male | 37 | 2025 | 63194 | 0.410 |
Why?
| Viral Matrix Proteins | 4 | 2008 | 26 | 0.400 |
Why?
| Joints | 1 | 2013 | 95 | 0.400 |
Why?
| Female | 39 | 2025 | 68510 | 0.400 |
Why?
| Sleep | 1 | 2018 | 676 | 0.400 |
Why?
| Risk Factors | 20 | 2025 | 9767 | 0.390 |
Why?
| Complement C3d | 7 | 2010 | 64 | 0.370 |
Why?
| Hypertension | 1 | 2020 | 1243 | 0.370 |
Why?
| Emphysema | 2 | 2023 | 95 | 0.360 |
Why?
| Genetic Loci | 4 | 2022 | 274 | 0.340 |
Why?
| Autoimmunity | 3 | 2022 | 860 | 0.340 |
Why?
| Adult | 18 | 2024 | 35510 | 0.310 |
Why?
| Follow-Up Studies | 8 | 2022 | 4915 | 0.310 |
Why?
| Disease Progression | 5 | 2024 | 2613 | 0.310 |
Why?
| Calcinosis | 1 | 2010 | 232 | 0.300 |
Why?
| Diabetic Angiopathies | 1 | 2010 | 263 | 0.300 |
Why?
| Prospective Studies | 11 | 2024 | 7079 | 0.300 |
Why?
| Cardiovascular Diseases | 3 | 2025 | 2024 | 0.290 |
Why?
| Genotype | 7 | 2024 | 1832 | 0.280 |
Why?
| Viral Envelope Proteins | 1 | 2007 | 81 | 0.270 |
Why?
| HLA-DR4 Antigen | 1 | 2007 | 78 | 0.270 |
Why?
| Linkage Disequilibrium | 2 | 2024 | 256 | 0.260 |
Why?
| Phenotype | 9 | 2025 | 3058 | 0.260 |
Why?
| Aged | 17 | 2025 | 22083 | 0.250 |
Why?
| Rheumatoid Factor | 1 | 2007 | 168 | 0.250 |
Why?
| Glycoproteins | 1 | 2007 | 337 | 0.250 |
Why?
| Tobacco Use | 2 | 2023 | 61 | 0.250 |
Why?
| Population Surveillance | 2 | 2021 | 428 | 0.240 |
Why?
| Genomic Structural Variation | 1 | 2025 | 12 | 0.240 |
Why?
| Receptors, CCR2 | 1 | 2025 | 37 | 0.240 |
Why?
| Case-Control Studies | 7 | 2025 | 3342 | 0.240 |
Why?
| Genetic Markers | 2 | 2019 | 339 | 0.240 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 149 | 0.230 |
Why?
| Alcohol Drinking | 2 | 2022 | 751 | 0.230 |
Why?
| Acyltransferases | 2 | 2023 | 53 | 0.230 |
Why?
| Vitamin D-Binding Protein | 2 | 2016 | 15 | 0.220 |
Why?
| Cohort Studies | 7 | 2023 | 5407 | 0.220 |
Why?
| Longitudinal Studies | 6 | 2024 | 2715 | 0.220 |
Why?
| Receptors, Calcitriol | 2 | 2016 | 53 | 0.210 |
Why?
| Liver | 3 | 2023 | 1833 | 0.210 |
Why?
| Plaque, Atherosclerotic | 1 | 2023 | 55 | 0.210 |
Why?
| Autoimmune Diseases | 1 | 2007 | 425 | 0.210 |
Why?
| Drug Repositioning | 1 | 2023 | 25 | 0.210 |
Why?
| Artificial Intelligence | 2 | 2023 | 248 | 0.210 |
Why?
| Tomography, Emission-Computed | 1 | 2022 | 66 | 0.200 |
Why?
| Peptides, Cyclic | 2 | 2015 | 255 | 0.200 |
Why?
| Risk Assessment | 5 | 2019 | 3260 | 0.200 |
Why?
| Population Health | 1 | 2023 | 45 | 0.200 |
Why?
| Hyperlipidemias | 1 | 2023 | 126 | 0.200 |
Why?
| Vital Capacity | 4 | 2024 | 291 | 0.190 |
Why?
| Airway Obstruction | 1 | 2024 | 149 | 0.190 |
Why?
| Liver Cirrhosis | 2 | 2023 | 275 | 0.190 |
Why?
| Internationality | 1 | 2022 | 148 | 0.190 |
Why?
| Symptom Flare Up | 1 | 2021 | 38 | 0.190 |
Why?
| Models, Genetic | 1 | 2024 | 591 | 0.180 |
Why?
| Lung | 9 | 2023 | 3752 | 0.180 |
Why?
| Pulmonary Artery | 3 | 2024 | 1030 | 0.180 |
Why?
| Atrial Fibrillation | 1 | 2025 | 379 | 0.170 |
Why?
| Muscular Atrophy | 1 | 2021 | 79 | 0.170 |
Why?
| Mutagenesis, Site-Directed | 4 | 2010 | 358 | 0.170 |
Why?
| Amino Acid Substitution | 4 | 2010 | 281 | 0.170 |
Why?
| China | 1 | 2020 | 191 | 0.170 |
Why?
| Linear Models | 2 | 2019 | 816 | 0.170 |
Why?
| Respiratory Function Tests | 2 | 2019 | 583 | 0.170 |
Why?
| Transcriptome | 2 | 2023 | 883 | 0.170 |
Why?
| Gene Frequency | 4 | 2024 | 504 | 0.170 |
Why?
| Quantitative Trait, Heritable | 1 | 2020 | 119 | 0.170 |
Why?
| Alleles | 3 | 2019 | 845 | 0.170 |
Why?
| Prevalence | 6 | 2023 | 2564 | 0.170 |
Why?
| Pulmonary Heart Disease | 1 | 2019 | 6 | 0.170 |
Why?
| Molecular Epidemiology | 1 | 2019 | 63 | 0.160 |
Why?
| Prognosis | 4 | 2024 | 3788 | 0.160 |
Why?
| Blood Pressure Determination | 1 | 2020 | 150 | 0.160 |
Why?
| gamma-Glutamyltransferase | 1 | 2019 | 40 | 0.160 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3624 | 0.160 |
Why?
| Nuclear Family | 1 | 2019 | 51 | 0.160 |
Why?
| Whole Genome Sequencing | 3 | 2025 | 131 | 0.160 |
Why?
| Binding Sites | 5 | 2010 | 1241 | 0.150 |
Why?
| Hepatitis C | 2 | 2011 | 234 | 0.150 |
Why?
| Antigens, Viral | 1 | 2019 | 174 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 134 | 0.150 |
Why?
| Heart Ventricles | 2 | 2020 | 768 | 0.150 |
Why?
| Protein Binding | 7 | 2010 | 2106 | 0.150 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2017 | 32 | 0.140 |
Why?
| Vascular Remodeling | 1 | 2019 | 181 | 0.140 |
Why?
| Blood Pressure | 2 | 2023 | 1735 | 0.140 |
Why?
| Severity of Illness Index | 3 | 2021 | 2739 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 236 | 0.130 |
Why?
| United States | 5 | 2020 | 13938 | 0.130 |
Why?
| Lung Diseases | 1 | 2023 | 723 | 0.130 |
Why?
| Lipids | 1 | 2020 | 624 | 0.130 |
Why?
| Protein Structure, Tertiary | 3 | 2008 | 836 | 0.130 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 18 | 0.130 |
Why?
| Crystallography, X-Ray | 6 | 2010 | 434 | 0.130 |
Why?
| Complement C3b | 3 | 2007 | 32 | 0.130 |
Why?
| Fatigue | 1 | 2018 | 320 | 0.130 |
Why?
| Mutation, Missense | 2 | 2008 | 318 | 0.130 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 79 | 0.130 |
Why?
| Body Mass Index | 3 | 2021 | 2266 | 0.120 |
Why?
| Antibodies, Viral | 1 | 2019 | 603 | 0.120 |
Why?
| Machine Learning | 1 | 2019 | 447 | 0.120 |
Why?
| Abdominal Fat | 2 | 2017 | 40 | 0.110 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 137 | 0.110 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 66 | 0.110 |
Why?
| Multivariate Analysis | 3 | 2019 | 1496 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 4 | 2019 | 816 | 0.110 |
Why?
| Europe | 3 | 2022 | 362 | 0.110 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 374 | 0.100 |
Why?
| Hyperglycemia | 1 | 2016 | 326 | 0.100 |
Why?
| Calcium | 1 | 2018 | 1180 | 0.100 |
Why?
| Recombinant Proteins | 5 | 2007 | 1284 | 0.100 |
Why?
| Family Health | 1 | 2013 | 194 | 0.100 |
Why?
| Models, Molecular | 6 | 2008 | 1483 | 0.100 |
Why?
| Sample Size | 2 | 2022 | 115 | 0.100 |
Why?
| Peptide Fragments | 3 | 2007 | 686 | 0.100 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 5068 | 0.100 |
Why?
| Mutant Proteins | 2 | 2010 | 98 | 0.100 |
Why?
| Dyspnea | 2 | 2024 | 239 | 0.090 |
Why?
| Proportional Hazards Models | 3 | 2019 | 1210 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2022 | 1741 | 0.090 |
Why?
| Patient Care Team | 1 | 2016 | 602 | 0.090 |
Why?
| Texas | 1 | 2012 | 227 | 0.090 |
Why?
| Antibodies, Monoclonal | 4 | 2007 | 1359 | 0.090 |
Why?
| Registries | 1 | 2019 | 1884 | 0.090 |
Why?
| Protein Interaction Mapping | 2 | 2008 | 109 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 513 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2018 | 1943 | 0.090 |
Why?
| K562 Cells | 2 | 2007 | 82 | 0.090 |
Why?
| Epidemics | 1 | 2011 | 83 | 0.080 |
Why?
| Life Style | 1 | 2012 | 460 | 0.080 |
Why?
| Depression | 1 | 2018 | 1292 | 0.080 |
Why?
| Quality of Life | 1 | 2021 | 2693 | 0.080 |
Why?
| Intra-Abdominal Fat | 1 | 2009 | 88 | 0.080 |
Why?
| Retrospective Studies | 3 | 2021 | 14571 | 0.070 |
Why?
| Sex Factors | 2 | 2020 | 1953 | 0.070 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2008 | 137 | 0.070 |
Why?
| Regression Analysis | 2 | 2022 | 984 | 0.070 |
Why?
| Exercise Tolerance | 2 | 2020 | 269 | 0.070 |
Why?
| Meta-Analysis as Topic | 2 | 2020 | 169 | 0.070 |
Why?
| Point Mutation | 1 | 2008 | 224 | 0.070 |
Why?
| Polymorphism, Genetic | 1 | 2010 | 639 | 0.070 |
Why?
| Bottle Feeding | 1 | 2007 | 21 | 0.070 |
Why?
| Bronchodilator Agents | 2 | 2021 | 245 | 0.070 |
Why?
| Histocompatibility Testing | 1 | 2007 | 120 | 0.070 |
Why?
| Insulin | 1 | 2017 | 2320 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 2077 | 0.070 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 5376 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 740 | 0.060 |
Why?
| Interferon-alpha | 1 | 2006 | 192 | 0.060 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2025 | 52 | 0.060 |
Why?
| Chemokine CCL2 | 1 | 2025 | 118 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 230 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 12 | 0.050 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 23 | 0.050 |
Why?
| United Kingdom | 1 | 2024 | 259 | 0.050 |
Why?
| Carotid Intima-Media Thickness | 1 | 2023 | 91 | 0.050 |
Why?
| Pandemics | 1 | 2011 | 1491 | 0.050 |
Why?
| Multimorbidity | 1 | 2023 | 46 | 0.050 |
Why?
| Computer Simulation | 2 | 2024 | 941 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2019 | 7064 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2024 | 262 | 0.050 |
Why?
| Biomarkers | 1 | 2013 | 3896 | 0.050 |
Why?
| Monocytes | 1 | 2025 | 543 | 0.050 |
Why?
| B-Lymphocytes | 1 | 2007 | 823 | 0.050 |
Why?
| Pectoralis Muscles | 1 | 2021 | 17 | 0.050 |
Why?
| Biology | 1 | 2023 | 83 | 0.050 |
Why?
| Reference Values | 1 | 2023 | 780 | 0.050 |
Why?
| Colorado | 1 | 2012 | 4394 | 0.050 |
Why?
| Epitope Mapping | 1 | 2001 | 57 | 0.050 |
Why?
| Logistic Models | 1 | 2007 | 1979 | 0.050 |
Why?
| Bronchi | 1 | 2022 | 240 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 174 | 0.040 |
Why?
| Ligands | 4 | 2006 | 614 | 0.040 |
Why?
| Cell Line, Tumor | 1 | 2008 | 3184 | 0.040 |
Why?
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 35 | 0.040 |
Why?
| Inheritance Patterns | 1 | 2020 | 46 | 0.040 |
Why?
| Myocytes, Cardiac | 1 | 2025 | 495 | 0.040 |
Why?
| Molecular Sequence Annotation | 1 | 2020 | 88 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 431 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| Models, Statistical | 1 | 2024 | 626 | 0.040 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 449 | 0.040 |
Why?
| Hepacivirus | 2 | 2011 | 235 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2019 | 9 | 0.040 |
Why?
| Cytochrome P-450 CYP2B6 | 1 | 2019 | 9 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 130 | 0.040 |
Why?
| Cytochrome P450 Family 2 | 1 | 2019 | 12 | 0.040 |
Why?
| Age Factors | 1 | 2007 | 3120 | 0.040 |
Why?
| Walk Test | 1 | 2019 | 69 | 0.040 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 41 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2021 | 664 | 0.040 |
Why?
| Surface Plasmon Resonance | 3 | 2006 | 88 | 0.040 |
Why?
| Binding, Competitive | 3 | 2006 | 199 | 0.040 |
Why?
| Genomics | 1 | 2023 | 716 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 441 | 0.040 |
Why?
| Organ Specificity | 1 | 2019 | 291 | 0.040 |
Why?
| Cluster Analysis | 1 | 2019 | 478 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 1013 | 0.040 |
Why?
| Self Report | 1 | 2022 | 806 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 111 | 0.040 |
Why?
| Body Composition | 1 | 2021 | 657 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 285 | 0.040 |
Why?
| Adrenal Cortex Hormones | 1 | 2021 | 519 | 0.030 |
Why?
| Mortality | 1 | 2019 | 308 | 0.030 |
Why?
| Chronic Disease | 1 | 2023 | 1706 | 0.030 |
Why?
| Environment | 1 | 2019 | 347 | 0.030 |
Why?
| Diagnostic Imaging | 1 | 2019 | 330 | 0.030 |
Why?
| Incidence | 2 | 2015 | 2635 | 0.030 |
Why?
| Cause of Death | 1 | 2018 | 393 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2018 | 864 | 0.030 |
Why?
| Risk | 1 | 2019 | 856 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2017 | 356 | 0.030 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2015 | 28 | 0.030 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2015 | 56 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2017 | 356 | 0.030 |
Why?
| Amino Acid Sequence | 3 | 2006 | 2041 | 0.030 |
Why?
| Receptors, IgE | 2 | 2006 | 44 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2006 | 2819 | 0.030 |
Why?
| Repetitive Sequences, Amino Acid | 2 | 2005 | 17 | 0.030 |
Why?
| Mutagenesis | 2 | 2006 | 181 | 0.030 |
Why?
| Genome, Human | 1 | 2015 | 392 | 0.030 |
Why?
| Solutions | 2 | 2005 | 148 | 0.030 |
Why?
| Child, Preschool | 1 | 2007 | 10450 | 0.020 |
Why?
| Egypt | 1 | 2011 | 10 | 0.020 |
Why?
| Israel | 1 | 2011 | 47 | 0.020 |
Why?
| Asia | 1 | 2011 | 58 | 0.020 |
Why?
| Consensus Sequence | 2 | 2001 | 72 | 0.020 |
Why?
| Inflammation | 1 | 2022 | 2668 | 0.020 |
Why?
| Protein Conformation | 2 | 2006 | 853 | 0.020 |
Why?
| Time Factors | 2 | 2011 | 6518 | 0.020 |
Why?
| Australia | 1 | 2011 | 246 | 0.020 |
Why?
| Canada | 1 | 2011 | 348 | 0.020 |
Why?
| Molecular Dynamics Simulation | 1 | 2010 | 217 | 0.020 |
Why?
| Infant | 1 | 2021 | 8992 | 0.020 |
Why?
| Child | 1 | 2007 | 20805 | 0.020 |
Why?
| Spodoptera | 1 | 2006 | 37 | 0.020 |
Why?
| Myxovirus Resistance Proteins | 1 | 2006 | 13 | 0.020 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2006 | 81 | 0.020 |
Why?
| HSP40 Heat-Shock Proteins | 1 | 2006 | 25 | 0.020 |
Why?
| Glycosylation | 1 | 2006 | 146 | 0.020 |
Why?
| Polysaccharides | 1 | 2006 | 81 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2006 | 155 | 0.020 |
Why?
| Sodium Chloride | 1 | 2006 | 138 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 538 | 0.010 |
Why?
| Protein Structure, Quaternary | 1 | 2005 | 122 | 0.010 |
Why?
| Static Electricity | 1 | 2005 | 117 | 0.010 |
Why?
| Dimerization | 1 | 2005 | 188 | 0.010 |
Why?
| Animals | 4 | 2010 | 34600 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2006 | 466 | 0.010 |
Why?
| Multiprotein Complexes | 1 | 2005 | 147 | 0.010 |
Why?
| Neutrons | 1 | 2002 | 9 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2005 | 1044 | 0.010 |
Why?
| Scattering, Radiation | 1 | 2002 | 97 | 0.010 |
Why?
| Antigen-Antibody Complex | 1 | 2001 | 84 | 0.010 |
Why?
| Protein Sorting Signals | 1 | 2001 | 19 | 0.010 |
Why?
| Pichia | 1 | 2001 | 22 | 0.010 |
Why?
| Ultracentrifugation | 1 | 2001 | 48 | 0.010 |
Why?
| Hydrogen Bonding | 1 | 2001 | 149 | 0.010 |
Why?
| Cell Line | 1 | 2006 | 2737 | 0.010 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 136 | 0.010 |
Why?
| Sequence Alignment | 1 | 2001 | 330 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2001 | 338 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2001 | 522 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2001 | 531 | 0.010 |
Why?
| Protein Folding | 1 | 2001 | 265 | 0.010 |
Why?
| Complement Activation | 1 | 2002 | 365 | 0.010 |
Why?
| Cells, Cultured | 1 | 2006 | 4010 | 0.010 |
Why?
| HIV-1 | 1 | 2001 | 842 | 0.010 |
Why?
| Models, Biological | 1 | 2002 | 1695 | 0.010 |
Why?
| Mice | 2 | 2002 | 16644 | 0.010 |
Why?
| Mice, Knockout | 1 | 2001 | 2765 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2001 | 1924 | 0.010 |
Why?
|
|
Young's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|